Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
FDA simplifies Institutional Review Board review requirements for physicians seeking patient expanded access
October 4, 2017 Off

FDA simplifies Institutional Review Board review requirements for physicians seeking patient expanded access

By Dino Mustafić

FDA has announced updates to three final guidances, including Form FDA 3926 and its instructions, to simplify Institutional Review Board (IRB)…

Timing of oral dosing relative to meals drove the lower than expected drug exposures
October 4, 2017 Off

Timing of oral dosing relative to meals drove the lower than expected drug exposures

By Dino Mustafić

Data presented by Tetraphase Pharmaceuticals at IDWeek confirmed that the timing of oral dosing relative to meals drove the lower…

Gilead, MPP: single-tablet regimen has potential to simplify the management of HIV
October 4, 2017 Off

Gilead, MPP: single-tablet regimen has potential to simplify the management of HIV

By Dino Mustafić

The Medicines Patent Pool (MPP) today announced a licence with Gilead Sciences for bictegravir (BIC), now under review in the United…

OptiBiotix Health launches SlimBiome and LPLDL
October 4, 2017 Off

OptiBiotix Health launches SlimBiome and LPLDL

By Dino Mustafić

OptiBiotix Health has kicked off with its SlimBiome and LPLDL products at Supply Side West in Las Vegas, in late September 2017.

October 4, 2017 Off

Evgen Pharma gets first European manufacturing patent

By Dino Mustafić

Evgen Pharma got the grant of the first European patent for its lead product, SFX-01.

October 4, 2017 Off

ImmuPharma, Lanstead Capital finish sharing deal, Phase III results for Lupuzor in Q1 2018

By Dino Mustafić

ImmuPharma has completed a sharing agreement with Lanstead Capital from February 2016, for supporting of ImmuPharma’s pivotal Phase III clinical trial…

FDA accepts sNDA filing for Allergan’s pneumonia drug
October 3, 2017 Off

FDA accepts sNDA filing for Allergan’s pneumonia drug

By Dino Mustafić

The U.S. Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for Allergan’s Avycaz (ceftazidime and avibactam) for priority review.

Sanofi appoints new EVP Diabetes & Cardiovascular
October 3, 2017 Off

Sanofi appoints new EVP Diabetes & Cardiovascular

By Dino Mustafić

Sanofi has appointed Stefan Oelrich as Executive Vice President Diabetes & Cardiovascular (DCV), effectively immediately.

Novartis’s Alcon introduces new innovations in cataract surgery at ESCRS 2017 annual congress
October 2, 2017 Off

Novartis’s Alcon introduces new innovations in cataract surgery at ESCRS 2017 annual congress

By Dino Mustafić

Alcon, a division of Novartis, will introduce Clareon, the intraocular lens (IOL) with the most advanced optic material available in an automated, disposable, pre-loaded delivery system, at the XXXV European Society of Cataract & Refractive Surgeons (ESCRS) congress taking place October 7 – 11 in Lisbon, Portugal.

Eli Lilly in leadership chances
September 29, 2017 Off

Eli Lilly in leadership chances

By Dino Mustafić

Eli Lilly has made certain leadership changes, promoting several experienced Lilly leaders to executive roles, effective in 2018.

Posts pagination

Previous 1 … 3,432 3,433 3,434 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine